Li Jingyang increased his holding of Huakang Biomed (08622) by approximately 139 million shares, with a price of 0.1175 Hong Kong dollars per share.
On January 10th, Li Jingyang increased his holdings of Huakang Biomedical (08622) by 138.672 million shares, with a price of 0.1175 Hong Kong dollars per share, for a total amount of 16.29396 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on January 10th, Li Jingyang increased his holdings of Huakang Biomedical (08622) by 138.672 million shares, at a price of HK$0.1175 per share, for a total amount of HK$16.29396 million. After the increase, the latest number of shares held is 138.672 million, with a latest shareholding percentage of 27.71%.
Related Articles
US Stock Market Move | NIO Inc. Sponsored ADR Class A (NIO.US) rises more than 4%, Li Bin reiterates fourth-quarter profit.
OURGAME (06899): Li Yangyang and Choi Shun have collectively sold 179 million shares of the company.
US Stock Market Move | Faraday Future Intelligent Electric, Inc. (FFAI.US) rose more than 5%. Its subsidiary FXSuperOne completed the first batch of complete sets of components procurement.
US Stock Market Move | NIO Inc. Sponsored ADR Class A (NIO.US) rises more than 4%, Li Bin reiterates fourth-quarter profit.
OURGAME (06899): Li Yangyang and Choi Shun have collectively sold 179 million shares of the company.
US Stock Market Move | Faraday Future Intelligent Electric, Inc. (FFAI.US) rose more than 5%. Its subsidiary FXSuperOne completed the first batch of complete sets of components procurement.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
